Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3047-2026

STA Staclot Protein S Recall

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

FDA recall Class II

Ongoing

FDA lists this Class II recall for STA Staclot Protein S. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3047-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 29, 2026
FDA report date
Sep 9, 2026
Quantity in commerce
5220 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Affected model & UDI checker

Search the exact identifiers published for Z-3047-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
00746-ReagentSTA Staclot Protein SCheck source noticeNot specified
FDA code information

UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027

View the original FDA recall notice

Why was this product recalled?

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

What actions did Diagnostica Stago, Inc. take?

Diagnostica Stago issued an URGENT: MEDICAL DEVICE RECALL (REMOVAL) notice to its consignees on 7/29/2026 via email. The notice described the issue, risk assessment, and requested the following: "Actions Required To prevent potential workflow disruptions associated with the increased recalibration frequency, we request that you: " Immediately discontinue use of STA-Staclot Protein S, Lot 273074. " Dispose of any remaining inventory of the affected lot in accordance with your facility's procedures and local regulations. " Complete, sign, and return the enclosed Acknowledgement Form by email to confirm receipt and understanding of this notification. Stago will provide a credit for the destroyed kits you indicate on the Acknowledgement Form." For questions regarding this notice or require assistance, please contact Stago's 24/7 Hotline at 1-800-725-0607.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology